A reminder that Dr. Pestell makes the poster presentation tomorrow and his podium presentation on Saturday.
Abstract Title:
CCR5 inhibition with leronlimab is associated with enhanced PD-L1 expression, ICI response, and long‑term survival in metastatic TNBC